Safe, long-term sorafenib treatment of patients with hepatocellular carcinoma is associated with metabolic ratio and exposure to a major metabolite, sorafenib N-oxide: a preliminary study

DRUG METABOLISM REVIEWS(2016)

引用 0|浏览4
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要